Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Using the Inverness Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in HIV-Positive TB Suspects

NCT01525134 is registered in ClinicalTrials.gov with Tuberculosis Clinical Diagnostics Research Consortium as lead sponsor.

NCT NCT01525134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01525134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Using the Inverness Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in HIV-Positive TB Suspects
Lead sponsor
Tuberculosis Clinical Diagnostics Research Consortium
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2011
Completion date
April 30, 2012
Enrollment
504 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, tuberculosis, miliary, tuberculosis, pulmonary